The effects of quetiapine XR [extended-release] on cognition, mood and anxiety symptoms in SSRI [selective serotonin reuptake inhibitor]-resistant unipolar depression.
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2010
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 15 Nov 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 15 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2010 Planned end date changed from 1 May 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.